PROUDLY ORGANIZED AND SPONSORED BY
This will be a virtual event Chaired by ACP/Dr. Ellen Sam. The virtual venue will be via Zoom
AGENDA
Tuesday 25th May 2022
CHAIRPERSON: ACP/Dr. Ellen Sam
i. Opening Remarks: Mawuli Atiemo
ii. Introduction of Chairperson: Lois Papanko
iii. Chairperson’s Response: ACP/Dr. Ellen Sam
iv. “Management of Type 2 Diabetes Beyond Glucose Control; The role of SGLT2 Inhibitors”: Pharm Asiwome Aggor
v. SGLT2 Inhibitors in Heart Failure Management: Current Trends: Dr. Marc Dzradosi
vi. Management of Lipids in Type 2 Diabetes; The role of Statins: Pharm Naana Aboagye-Asare
vii. Question and Answer Session: Dr Ellen Sam, Pharm Naana Aboagye-Asare, Pharm Asiwome Aggor, Dr Marc Dzradosi
viii. Forxiga and Crestor presentation: Lois Papanko
ix. Closing Remarks: Dr. Ellen Sam, Lois Papanko
Diabetes and heart disease often go hand in hand. Over time, high blood sugar can damage blood vessels and the nerves that control a patient's heart. Individuals with diabetes are also more likely to have other conditions that raise the risk for heart disease such as high blood pressure, high levels of LDL, high triglycerides, etc.
This event aims to educate Pharmacists on the current trends and acceptable practices in the management of Diabetes, Heart Failure and Dislipidemia, with regards to SGLT2 receptor blockers and Statins.
Pharm.D, FGCPharm, MPSGh.
Clinical Pharmacy Specialist / Lecturer
Head of Pharmaceutical Services – International Maritime Hospital.
Dr Marc K. Dzradosi has over fifteen (15) years’ experience in Hospital based Clinical Pharmacy Services, Academia, Research, Healthcare Administration, Public Health, Nutrition, and Exercise Science.
View full profile / coursesBPharm, MSc,
Clinical Pharmacist
National Cardiothoracic Center, Korle Bu Teaching Hospital
View full profile / coursesBPharm, MSc
Hospital Manager
Port Medical Center, Tema
View full profile / courses